A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens
Clinical trial NCT00294736 · COMPLETED
Trial details
- NCT number
- NCT00294736
- Sponsor
- OSI Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2007-09-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.